Rain Therapeutics Stock Five Year Return
RAINDelisted Stock | USD 1.41 0.01 0.70% |
Rain Therapeutics fundamentals help investors to digest information that contributes to Rain Therapeutics' financial success or failures. It also enables traders to predict the movement of Rain Stock. The fundamental analysis module provides a way to measure Rain Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rain Therapeutics stock.
Rain |
Rain Therapeutics Company Five Year Return Analysis
Rain Therapeutics' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Rain Therapeutics has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
Rain Fundamentals
Return On Equity | -0.97 | |||
Return On Asset | -0.52 | |||
Current Valuation | (32.85 M) | |||
Shares Outstanding | 27.58 M | |||
Shares Owned By Insiders | 16.48 % | |||
Shares Owned By Institutions | 68.38 % | |||
Number Of Shares Shorted | 661.11 K | |||
Price To Book | 0.65 X | |||
EBITDA | (73.56 M) | |||
Net Income | (72.26 M) | |||
Cash And Equivalents | 90.73 M | |||
Cash Per Share | 3.41 X | |||
Total Debt | 277 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 7.20 X | |||
Book Value Per Share | 1.86 X | |||
Cash Flow From Operations | (65.76 M) | |||
Short Ratio | 1.90 X | |||
Earnings Per Share | (2.07) X | |||
Target Price | 1.58 | |||
Number Of Employees | 63 | |||
Beta | 0.27 | |||
Market Capitalization | 44.01 M | |||
Total Asset | 135.18 M | |||
Retained Earnings | (165.69 M) | |||
Working Capital | 111.66 M | |||
Z Score | 92.82 | |||
Net Asset | 135.18 M |
About Rain Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rain Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rain Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rain Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Rain Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rain Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Rain Stock
0.79 | BKRKY | Bank Rakyat | PairCorr |
0.7 | BKRKF | PT Bank Rakyat | PairCorr |
0.7 | PPERY | Bank Mandiri Persero | PairCorr |
0.66 | PPERF | Bank Mandiri Persero | PairCorr |
Moving against Rain Stock
0.93 | SSNLF | Samsung Electronics | PairCorr |
0.77 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.76 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
0.75 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.71 | CVX | Chevron Corp Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Rain Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rain Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rain Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rain Therapeutics to buy it.
The correlation of Rain Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rain Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rain Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rain Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Rain Stock
If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |